This Live Medscape Social Media Event explores the shared strategies for managing immunologic diseases across specialties, with a focus on integrating newer targeted therapies such as Janus kinase (JAK) inhibitors into patient-centered care. Healthcare professionals will learn to develop treatment approaches that align with patients' goals and preferences while overcoming common barriers to optimal care. The program addresses the varying confidence levels among specialists, will enhance their ab

3K views · 19 reactions | Watch: Standards of care in metastatic lung cancer are rapidly evolving, and patient outcomes have begun to shift. https://www.medscape.com/mtv/lung-cancer-s03/e04 | Medscape | Facebook

1.5K views · 20 reactions | ASCO 2019 conference guide....

Oral TKI or IV ADC for HER2 NSCLC? The first oral medication for this disease, Zongertinib, is now approved, joining established IV therapies like Trastuzumab deruxtecan. Our experts discuss how to choose ▶️ https://www.facebook.com/events/566988496426095 #Oncology #CME | Medscape

Looking to improve outcomes for patients with advanced COPD/emphysema? This free Medscape CME provides practical guidance on identifying and supporting candidates for endobronchial valve treatment. | Pulmonx